Built by great minds who have done the bench and the bits.
AI-assisted computational biology for antibody and protein research. We return analyses and reports your scientists can review — the laboratory work stays with your team.
A project starts from data you provide, such as sequences, structures or sequencing-derived files, and returns tables, figures and a written summary that states its inputs, methods and limits. The analysis helps narrow options and plan experiments; it does not replace them.
Clearer questions.
Better-planned experiments.
We believe computational analysis can help research teams decide what to test, so that experiments start from better-informed hypotheses.
Build the tools.
Run the analyses.
We build computational tools and use them to deliver analyses and reports for biopharma and biotechnology partners.
Jaspal Patil, PhD
Jaspal Patil, PhD, is the Founder & CEO of IndiskaAI, with over 20 years of overall experience spanning pharmaceutical sciences, biomedical research, biologics, and AI-assisted drug discovery. He holds a degree in Pharmaceutical Sciences and a PhD in Biomedical Sciences.
He is building IndiskaAI at the intersection of artificial intelligence, computational biology, and drug discovery, developing intelligent and data-driven approaches to address complex challenges in modern pharmaceutical R&D and support the identification and development of promising therapeutic candidates.
Together with the IndiskaAI team, he is working toward a future where AI-powered technologies enable smarter drug discovery, helping translate scientific insights into innovative therapeutic solutions.
Team IndiskaAI
IndiskaAI is an emerging biotech company driven by science, innovation and AI development.
Behind every idea at IndiskaAI is a team of hardworking, curious, and passionate individuals who believe in making a meaningful difference through science and technology. Our team brings together researchers, bioinformaticians, data scientists, and AI/ML engineers who work closely with real scientific challenges. We believe in learning continuously, thinking critically, and putting in the work needed to turn complex ideas into meaningful solutions.
With curiosity driving us and innovation guiding us, we are committed to contributing to the next generation of life sciences and drug discovery.